Supplementary Figure S2 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

<p>Supplementary Figure S2: A, Schematic representation of the structure of HBS-101, B, Structural representation of MDK highlighting its N-terminal (cyan) and C-terminal (green) regions. The missing residues between these domains are marked, indicating the gap that required reconstruction. C, The patched structure of MDK after incorporating the missing residues through loop modeling. This step ensured the structural connectivity between the N- and C-terminal regions, maintaining the protein’s overall continuity. D, The final refined 3D structure of MDK following loop refinement and extensive molecular dynamics (MD) simulations.</p>

Authors

Publication Details

Published
2025-09-02
DOI
https://doi.org/10.1158/1535-7163.30028861
Primary Topic
Glycosylation and Glycoproteins Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supplementary Figure S2 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

Dong Liang, Hareesh B. Nair, Megharani Mahajan, Huan Xie et al.
Glycosylation and Glycoproteins Research
article

Supplementary Figure S2 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

Dong Liang, Hareesh B. Nair, Megharani Mahajan, Huan Xie, John R. Sanchez, Jessica D. Johnson, Sridharan Jayamohan, Yang Wang, Suryavathi Viswanadhapalli, Manjeet K. Rao, Gangadhara R. Sareddy, Panneerdoss Subbarayalu, K.V. Dileep, Ratna K. Vadlamudi, Alondra L. Rodriguez Sanchez
article en

Abstract

<p>Supplementary Figure S2: A, Schematic representation of the structure of HBS-101, B, Structural representation of MDK highlighting its N-terminal (cyan) and C-terminal (green) regions. The missing residues between these domains are marked, indicating the gap that required reconstruction. C, The patched structure of MDK after incorporating the missing residues through loop modeling. This step ensured the structural connectivity between the N- and C-terminal regions, maintaining the protein’s overall continuity. D, The final refined 3D structure of MDK following loop refinement and extensive molecular dynamics (MD) simulations.</p>

Openalex Percentile: Top 80%
Glycosylation and Glycoproteins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Supplementary Figure S2 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer — Dong Liang, Hareesh B. Nair, et al. · (2025) | TGRS Research Map | TGRS